Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers Article

Kotsopoulos, Joanne, Gronwald, Jacek, Karlan, Beth Y et al. (2018). Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers . JAMA ONCOLOGY, 4(8), 1059-1065. 10.1001/jamaoncol.2018.0211

Open Access International Collaboration

cited authors

  • Kotsopoulos, Joanne; Gronwald, Jacek; Karlan, Beth Y; Huzarski, Tomasz; Tung, Nadine; Moller, Pal; Armel, Susan; Lynch, Henry T; Senter, Leigha; Eisen, Andrea; Singer, Christian F; Foulkes, William D; Jacobson, Michelle R; Sun, Ping; Lubinski, Jan; Narod, Steven A

sustainable development goals

authors

publication date

  • August 1, 2018

published in

keywords

  • ESTROGEN PLUS PROGESTIN
  • HEALTH OUTCOMES
  • HYSTERECTOMY
  • Life Sciences & Biomedicine
  • MENOPAUSE
  • MORTALITY
  • OVARIAN CONSERVATION
  • Oncology
  • POSTMENOPAUSAL WOMEN
  • SALPINGO-OOPHORECTOMY
  • Science & Technology
  • TIME

Digital Object Identifier (DOI)

publisher

  • AMER MEDICAL ASSOC

start page

  • 1059

end page

  • 1065

volume

  • 4

issue

  • 8